David D. Bowtell - Publications

Comprehensive detection of genetic and epigenetic alterations in cancer using long reads with TumorLens.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

Rethinking ovarian cancer III: the past decade and future directions.

Journal: Nature reviews. Cancer

Published: February 23, 2026

Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: December 07, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Research square

Published: November 19, 2025

PARP Inhibitor Maintenance After First-Line Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis.

Journal: JAMA network open

Published: November 05, 2025

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: October 03, 2025

Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Journal: Nature communications

Published: September 22, 2025

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis.

Journal: Gynecologic oncology

Published: March 05, 2025

Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.

Journal: European journal of human genetics : EJHG

Published: October 04, 2024

Predictive value of homologous recombination deficiency status for survival outcomes in primary tubo-ovarian high-grade serous carcinoma.

Journal: The Cochrane database of systematic reviews

Published: September 23, 2024

Overcoming intra-tumoral heterogeneity for biomarker discovery in the high-grade serous ovarian cancer proteome.

Journal: NPJ precision oncology

Published: September 19, 2024

Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.

Journal: Nature communications

Published: August 08, 2024